IRIDEX to Report Third Quarter 2020 Financial Results on November 9, 2020
October 26 2020 - 4:05PM
IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will
release financial results for the third quarter of 2020 after the
close of trading on Monday, November 9, 2020. The Company’s
management team will host a corresponding conference call beginning
at 2:00 p.m. PT / 5:00 p.m. ET.
Investors interested in listening to the conference call may do
so by dialing (844) 707-0665 for domestic callers or (703) 326-3030
for international callers, using conference ID: 5860026. A live and
archived webcast of the event will be available on the “Investors”
section of the Company’s website at: www.iridex.com.
About IRIDEXIRIDEX Corporation is a worldwide
leader in developing, manufacturing, and marketing innovative and
versatile laser-based medical systems, delivery devices and
consumable instrumentation for the ophthalmology market. The
Company’s proprietary MicroPulse® technology delivers a
differentiated treatment that provides safe, effective, and proven
treatment for targeted sight-threatening eye conditions. IRIDEX’s
current product line is used for the treatment of glaucoma and
diabetic macular edema (DME) and other retinal diseases. IRIDEX
products are sold in the United States through a direct sales force
and internationally primarily through a network of independent
distributors into more than 100 countries. For further information,
visit the IRIDEX website at www.iridex.com.
Investor Relations Contact:Leigh Salvo(415)
937-5404investors@iridex.com
Media Contact:Jamie Hall Pascale
Communications, LLC.(724) 417-0167pr@iridex.com
IRIDEX (NASDAQ:IRIX)
Historical Stock Chart
From Jul 2024 to Aug 2024
IRIDEX (NASDAQ:IRIX)
Historical Stock Chart
From Aug 2023 to Aug 2024